Talis Biomedical Corporation (TLIS)
OTCMKTS
· Delayed Price · Currency is USD
1.410
0.00 (0.00%)
Jun 10, 2025, 8:00 PM EDT
Talis Biomedical Revenue
Talis Biomedical had revenue of $408.00K in the twelve months ending June 30, 2024, down -85.69% year-over-year. In the year 2023, Talis Biomedical had annual revenue of $2.13M, down -55.65%.
Revenue (ttm)
408.00K
Revenue Growth
-85.69%
P/S Ratio
6.30
Revenue / Employee
4.12K
Employees
99
Market Cap
2.57M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Talis Biomedical News
- 8 months ago - Baker Bros. Advisors LP's Strategic Acquisition in Talis Biomedical Corp - GuruFocus
- 1 year ago - Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash - GlobeNewsWire
- 1 year ago - Talis Biomedical Corporation (TLIS) Q2 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update - GlobeNewsWire
- 2 years ago - Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023 - GlobeNewsWire
- 2 years ago - Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO) - GlobeNewsWire
- 2 years ago - Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 2 years ago - Talis Biomedical Announces 1-for-15 Reverse Stock Split - GlobeNewsWire